Concepedia

Sreetha Sidharthan

SS

16

Publications

1K

Citations

14

H-Index

2013

Active since

Affiliations

Gilead Sciences (United States)(Current)

University of Maryland, Baltimore

National Institute of Allergy and Infectious Diseases

National Institutes of Health Clinical Center

National Institutes of Health

Sreetha Sidharthan is an author at Gilead Sciences (United States) specializing in medicine, hepatology, and epidemiology.

ORCID

Top concepts

Publications per year

2013–2021

16

Publications

16

Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection

Anu Osinusi, Kerry Townsend, Anita Kohli et al. · JAMA · 2015 · 203 citations · Full text

Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study

Anita Kohli, Rama Kapoor, Zayani Sims et al. · The Lancet Infectious Diseases · 2015 · 165 citations · Full text

, , +11

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study

Anita Kohli, A. Osinusi, Zayani Sims et al. · The Lancet · 2015 · 151 citations

, , +9

Utility of Hepatitis C Viral Load Monitoring on Direct-Acting Antiviral Therapy

Sreetha Sidharthan, Anita Kohli, Zayani Sims et al. · Clinical Infectious Diseases · 2015 · 101 citations · Full text

High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study

Tess Petersen, Kerry Townsend, Lori A. Gordon et al. · Hepatology International · 2015 · 66 citations · Full text

Rows per page

1–5 of 16